The Deloitte 2024 Healthcare Generative AI Outlook study released this week takes a closer look at potential blind spots leaders may have as they implement generative artificial intelligence.WHY IT MATTERS
In the new report, Deloitte…
The landscape of healthcare and life sciences is rapidly changing, influenced by challenges from the Covid-19 pandemic. In 2024, several trends are emerging that could greatly affect the industry, said Dr. Asif Dhar, U.S….
Continue Reading
About 83% of life sciences and healthcare C-suite executives say that improving health equity is a top-10 goal in 2024, according to a recent report from Deloitte. In addition, 47% anticipate increasing health equity…
Continue Reading
Deloitte released a report last week predicting the key trends that will shape the healthcare landscape in 2024. For its report, the consulting firm surveyed 60 health system and health plan executives who work…
Continue Reading
What You Should Know:
– The US healthcare system is undergoing a period of significant transformation, driven by factors such as consolidation, digital transformation, and the rise of empowered consumers, according to Deloitte’s 2024 Health…
Continue Reading
The following is a guest article by Marcin Wudarczyk, PhD, Software Architect and CEO of GoSolve
In today’s fast-paced healthcare industry, having the right software can make all the difference in your organization’s success. However, the cost and…
Deloitte’s 2023 Health Care Consumer Survey reveals a prevalent consumer belief in the transformative power of generative AI within healthcare, with over 70% acknowledging its potential to revolutionize delivery. Notably, health-related concerns drive users…
Continue Reading
What You Should Know: A recent survey conducted by Deloitte’s Center for Health Solutions (Center) revealed a growing acceptance and optimism among consumers regarding the potential of Generative AI to revolutionize healthcare. Over half…
Continue Reading
Deloitte’s 2023 Health Care Consumer Survey unveils that 70%+ of generative AI users foresee a healthcare revolution. Health concerns propel consumer interest in AI adoption amid escalating healthcare costs and access worries. While 48%…
Continue Reading
Clinical Trial Platform Uncovers Hidden Signals and Optimizes Next Steps for More Adaptive, Successful, and Efficient Clinical Trials
PhaseV, a pioneer in causal machine learning (ML) technology that optimizes clinical trial design and analysis, announced today that it has…
